Tag Archives: Chronic obstructive pulmonary disease

Royal Philips announces #BreatheBoldly social initiative on World COPD Day

Philips joins COPD Foundation and family of late Leonard Nimoy in asking the world to #BreatheBoldly on social media to raise COPD awareness AMSTERDAM, 16-Nov-2016 — /EuropaWire/ — On World COPD Day, Royal Philips (NYSE: PHG, AEX: PHIA) is proud … Read the full press release

Boehringer Ingelheim launches campaign to raise public awareness of chronic obstructive pulmonary disease (COPD)

Your Time campaign calls for earlier action in COPD WHO expects COPD to be the third leading cause of death worldwide by 2030 – exceeded only by heart disease and stroke1 By the time most people know they have COPD, … Read the full press release

Novartis announced positive results from two pivotal Phase III clinical trial programs for QVA149 and NVA237 in patients with COPD

QVA149 improved lung function, breathlessness and health-related quality of life in moderate-to-severe COPD patients, according to EXPEDITION trial results[1]-[7] GEM 1 & 2 studies showed NVA237 provided significant and clinically meaningful improvements in lung function in moderate-to-severe COPD patients[8],[9] In … Read the full press release

AstraZeneca: The Lancet Respiratory Medicine published encouraging safety and efficacy data from Benralizumab Phase II COPD study

Results are among key AstraZeneca respiratory data being presented at 2014 European Respiratory Society International Congress LONDON, 8-9-2014 — /EuropaWire/ — AstraZeneca today announced that The Lancet Respiratory Medicine has published encouraging safety and efficacy data from a Phase IIa … Read the full press release

GlaxoSmithKline’s Incruse® (umeclidinium) gets European Commission marketing authorisation as maintenance bronchodilator treatment of COPD

London, 29-4-2014 — /EuropaWire/ — GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the European Commission has granted marketing authorisation for Incruse® (umeclidinium) as a once-daily, maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). Now licensed across … Read the full press release

On World COPD Day 2013 physicians and experts emphasize importance of 24hour symptoms relief of Chronic Obstructive Pulmonary Disease (COPD) sufferers

Most of the 64 million COPD patients around the world, including over 2 million in Spain, must contend with breathlessness, excessive mucus, chronic cough and other debilitating symptoms throughout  24hours a day The World Health Organization estimates that COPD kills … Read the full press release

University College London: Men experience higher burden of disease and lower life expectancy than women

21-5-2013 — /europawire.eu/ — Men experience a higher burden of disease and lower life expectancy than women, but policies focusing on the health needs of men are notably absent from the strategies of global health organisations, according to a Viewpoint article in this … Read the full press release